Noy Cohen Saban

2PUBLICATIONS
6CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Mar 03, 2023
Fc glycoengineering of a PD-L1 antibody harnesses Fcγ receptors for increased antitumor efficacy.

Noy Cohen Saban, Adam Yalin, Tomer Landsberger

|Feb 22, 2022
Bispecific antibodies increase the therapeutic window of CD40 agonists through selective dendritic cell targeting.

Ran Salomon, Hagar Rotem, Yonatan Katzenelenbogen

Pageof 1